At a Glance
Dosage
oral
| Level | MDEA | 5-MAPB |
|---|---|---|
| Threshold | 40 mg | 20 mg |
| Light | 70–120 mg | 40–60 mg |
| Common | 120–180 mg | 60–80 mg |
| Strong | 180–225 mg | 80–100 mg |
| Heavy | 225 mg | 100 mg |
Duration
oral
MDEA
oral
Total: 3 hrs – 6 hrsAfterglow
Onset20 min – 1 hrs
Come Up15 min – 30 min
Peak1.5 hrs – 2 hrs
Offset
Effects
Safety
Interaction: MDEA + 5-MAPB
No direct interaction data available between these substances. This does not mean the combination is safe.
MDEA — Dangerous Interactions
5-MAPB — Dangerous Interactions
Frequently Asked Questions
What is the difference between MDEA and 5-MAPB?
MDEA is classified as a Entactogen (Amphetamine, MDxx, Substituted amphetamines) while 5-MAPB is classified as a Entactogen (Substituted amphetamines, Substituted benzofurans). They share 22 effects in common, with 40 effects unique to MDEA and 4 unique to 5-MAPB.
Is it safe to combine MDEA and 5-MAPB?
There is no direct interaction data available for combining MDEA and 5-MAPB. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, MDEA or 5-MAPB?
At common doses via oral, MDEA is typically dosed at 120–180 mg while 5-MAPB is dosed at 60–80 mg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.